Pfizer acquired Pharmacia in 2003 in the largest pharmaceutical merger in history, valued at $60 billion. The merger strengthened Pfizer's portfolio in areas like oncology and endocrinology. It combined Pfizer's leadership in pharmaceutical revenues with Pharmacia's research in key therapeutic areas. While the deal enhanced Pfizer's market position and share prices, it also led to facility closures and job cuts following the integration of the two major companies.
3. Pfizer Inc.
• American Multinational Pharmaceutical Corporation.
(HQ - New York City)
• Largest Pharmaceutical corporation in terms of
revenues.
• Revenue - 67.42 Bn USD
• Income - 10.23 Bn USD
• Assets - 180 Bn USD
• Market Cap. – 201.59 Bn USD Corp.flv
4. Products
• More than 40 Genuine products in market under its title
• Famous Products - Lipitor
Difflucan
Zithromax
Celebrex
Bextra
• Feldene ( Piroxicam )
5. History & Development
• Est. : 1849 by C. Pfizer & C. Erhart
• HQ : Brooklyn
• Chemicals Company
• Santonin – Antiparasitic
• 1880 – Citric Acid
• WW1
• Fermentation
• WW2 & Penicillin
6. • 1950 : Terramycin
• 1950s, Pfizer was established in Belgium, Brazil, Canada,
Cuba, Iran, Mexico, Panama, Puerto Rico, Turkey and the
United Kingdom.
• During the 1980s and 1990s Pfizer underwent a period of
growth sustained by the discovery and marketing
of Zoloft, Lipitor, Norvasc,Zithromax, Aricept, Diflucan.
8. History & Development
• Est. – 1911 in Stockholm, Sweden by Gustav Felix
• Phospho – Energon
• WW2 – Polysaccharide dextran
• 1943 – Macrodex
• 1959 – Gel Filtration, Sephadex
• 1986 – Pharmacia Biotech.
• 1995 - Pharmacia Upjhon, London
• 1999 – Pharmacia & Upjhon merge with Monsanto
Company
9. Sequence of Mergers
G. D. Serale & Company
1985
2002
Monsanto Company
2000
Pharmacia Biotech aquired by Upjhon,
1995
10. Merger
• Pharmacia Corp. aquired by Pfizer on July 2003
• Deal was finalized for 60 Bn USD
• Largest merger in Global Pharmaceutical History
• Reasons
1.Marketing rights for Celebrex
2.To position Pfizer as a long term global leader in
pharmaceutical industry
3.To strengthen research in oncology medicines.
11. Post Merger Consequences
• 12 Products of celebrex with annual revenue of more than
1 Bn USD
• Enhanced therapeutic portfolio of Pfizer in oncology,
opthalmology and endocrinology
• Increased share prices of Pfizer
• Closure of some of Pharmacia’s facilities and job cuts
12. Thank You ..!
&
Questions …..If
Any ?
- Vishwajeet Aher/02
- Shreyas Alai/03
- Vaibhav Agrawal/01
12